Curis
CRIS
#11066
Rank
HK$35 M
Marketcap
HK$3.68
Share price
-23.59%
Change (1 day)
-58.18%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -HK$112.35

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$111.47. In 2025 the company made an earnings per share (EPS) of -HK$186.65 an increase over its 2024 EPS that were of -HK$1,102.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$112.35-39.81%
2025-HK$186.65-83.07%
2024-HK$1,102-22.15%
2023-HK$1,416-26.17%
2022-HK$1,91722.3%
2021-HK$1,568-25.37%
2020-HK$2,101-30.93%
2019-HK$3,042-2.02%
2018-HK$3,104
2016-HK$7,055-10%
2015-HK$7,839138.1%
2014-HK$3,29240%
2013-HK$2,352-25%
2012-HK$3,13666.67%
2011-HK$1,881

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$27.12-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.10-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.93-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$39.51-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA